Remote digital cognitive assessment for aging and dementia using the Oxford Cognitive Testing Portal OCTAL - Report - MDSpire

Remote digital cognitive assessment for aging and dementia using the Oxford Cognitive Testing Portal OCTAL

  • By

  • Sijia Zhao

  • Sofia Toniolo

  • Qian-Yuan Tang

  • Anna Scholcz

  • Akke Ganse-Dumrath

  • Claudia Gendarini

  • M. John Broulidakis

  • Sian Thompson

  • Sanjay G. Manohar

  • Masud Husain

  • January 15, 2026

  • 0 min

Share

Clinical Report: Digital Cognitive Evaluation via Oxford Cognitive Testing Portal (OCTAL)

Overview

The Oxford Cognitive Testing Portal (OCTAL) is a validated, remote, browser-based platform for assessing multiple cognitive domains relevant to aging and dementia. It demonstrates strong cross-cultural applicability, lifespan sensitivity, and clinical utility, effectively distinguishing Alzheimer’s disease dementia from subjective cognitive decline with high accuracy.

Background

Dementia prevalence is rising globally, creating an urgent need for scalable cognitive assessment tools adaptable for both clinical and research settings. Traditional paper-based tests have limitations in accessibility and scalability, especially for remote or large-scale applications. Digital cognitive assessments like OCTAL offer a modular, sustainable solution that can be administered remotely, covering memory, attention, visuospatial, and executive functions. Validation across diverse populations and age groups is critical to ensure reliability and clinical relevance.

Data Highlights

Study CohortSample Size (N)Key OutcomeMetric
Cross-cultural validation (English & Chinese younger adults)Not specifiedEquivalent task performanceQualitative equivalence
Lifespan sensitivity (mid- to late-adulthood)Not specifiedDomain-specific aging trajectories mappedQualitative mapping
Memory clinic cohort1945-minute OCTAL screen distinguishing AD dementia from subjective cognitive declineAUC = 0.92
Memory clinic cohort (20-minute subset)194Enhanced discrimination of AD dementiaAUC = 0.97 (p = 0.04 vs 5-min screen)
Test-retest reliability118Reliability of OCTAL tasksICC ≥ 0.79

Key Findings

  • OCTAL provides remote, browser-based cognitive testing across multiple domains including memory, attention, visuospatial, and executive functions.
  • Validation studies (N=1664) confirm OCTAL’s applicability across cultures and its sensitivity to cognitive changes across the adult lifespan.
  • In a memory clinic cohort (N=194), the 5-minute OCTAL screen distinguished Alzheimer’s disease dementia from subjective cognitive decline with an AUC of 0.92, comparable to standard paper-based tests.
  • A 20-minute OCTAL subset further improved diagnostic accuracy (AUC = 0.97), significantly outperforming the shorter screen (p=0.04).
  • Test-retest reliability was very good, with intraclass correlation coefficients (ICC) ≥ 0.79 in 118 participants.
  • OCTAL’s open, modular architecture supports sustainability and evolution for research and clinical applications.

Clinical Implications

OCTAL offers a scalable, validated tool for remote cognitive assessment that can facilitate early detection and monitoring of dementia, including Alzheimer’s disease. Its strong psychometric properties and cross-cultural validation support its use in diverse clinical populations. The platform’s modular design allows integration into large-scale research and clinical screening programs, potentially improving access and efficiency of cognitive evaluations.

Conclusion

The Oxford Cognitive Testing Portal represents a robust, flexible digital solution for cognitive assessment in aging and dementia, combining clinical accuracy with remote accessibility. Its validation across populations and cognitive domains positions it as a valuable tool for both clinical practice and research.

References

  1. Zhao et al. -- Digital Cognitive Evaluation for Aging and Dementia via the Oxford Cognitive Testing Portal (OCTAL)
  2. Nichols et al. 2022 -- Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050
  3. Alzheimer’s Society 2023 -- Improving Access to a Timely and Accurate Diagnosis of Dementia

Original Source(s)

Related Content